companydata.dkcompanydata.dk

Biosynex Nordic ApS: Financial statements 2021

CVR: 38417541

Source: annual report 2021, Danish Business Authority

01/01/2021 – 31/12/2021

Biosynex Nordic ApS (CVR 38417541) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 65,446,511 and a net result of DKK 49,728,503 compared with DKK 3,975,373 the year before. That is an increase of 1,177.4% compared with the year before. Equity in the 2021 report amounted to DKK 40,128,502. The solvency ratio was 40.5%. The company had 1 employee in the financial year.

Gross Profit
DKK 65,446,511
Profit/Loss
DKK 49,728,503
Equity
DKK 40,128,502
Total Assets
DKK 99,029,414
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2021-65.4M49.7M40.1M1
2020-5.1M4M4.2M0
2019-231K178K199K0
2018--35K-29K21K0
2017356K84066451K-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like Biosynex Nordic ApS

Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.

Try the lead list generator

Events in 2021

Janus von Platen-Hallermund joins Biosynex Nordic ApS as adm. dir.May 1, 2021

As of May 1, 2021, Janus von Platen-Hallermund is registered as adm. dir. of Biosynex Nordic ApS.

Preben Joffe steps down as adm. dir. of Biosynex Nordic ApSApr 30, 2021

As of April 30, 2021, Preben Joffe has stepped down as adm. dir. of Biosynex Nordic ApS.

Biosynex Nordic ApS: The 2020 annual report is outMar 9, 2021

Biosynex Nordic ApS has published its annual report for 2020. Gross profit came to DKK 5,123,345, and the net result was DKK 3,975,373.

Biosynex Nordic ApS appoints new auditorMar 3, 2021

As of March 3, 2021, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of Biosynex Nordic ApS.

Michael Lexner joins the board of Biosynex Nordic ApSMar 3, 2021

As of March 3, 2021, Michael Lexner has joined the board of directors of Biosynex Nordic ApS.

Preben Joffe joins the board of Biosynex Nordic ApSMar 3, 2021

As of March 3, 2021, Preben Joffe has joined the board of directors of Biosynex Nordic ApS.

Michael Daugbjerg joins the board of Biosynex Nordic ApSMar 3, 2021

As of March 3, 2021, Michael Daugbjerg has joined the board of directors of Biosynex Nordic ApS.

Finn Schwarz joins Biosynex Nordic ApS as chairmanMar 3, 2021

As of March 3, 2021, Finn Schwarz is registered as chairman of Biosynex Nordic ApS.

Medkoncept ApS changes name to Medkoncept A/SMar 3, 2021

On March 3, 2021, the company changed its name from Medkoncept ApS to Medkoncept A/S.

About Biosynex Nordic ApS

Biosynex Nordic ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2017. The company has been dissolved on 7 July 2025. The company was registered under the industry Billeddiagnostiske undersøgelser og medicinske laboratorieaktiviteter. The company was previously named Biosynex Nordic A/S and Medkoncept A/S. The company has 2 employees (2025). In 2023, the company reported a gross profit of DKK -1,062,001 and a net result of DKK -3,931,794 compared with DKK 41,802,660 the year before. Equity in the 2023 report amounted to DKK -3,814,178.

Source: annual report 2023, Danish Business Authority

Other financial years